Health and Wellness Informatics News
ASN and HHS are offering $10.5 million in funding for the development of a fully functioning artificial kidney that can perform all life-saving functions.
The U.S. Department of Health and Human Services and the American Society of Nephrology are jointly offering $10.5 million for phase 2 of the Artificial Kidney Prize Competition from the Kidney Innovation Accelerator.
They want ideas for developing prototype bioartificial kidneys or methods to help us develop them. The basic idea here is also to develop and produce a working artificial kidney fully.
People from ASN and HHS requested people from the fields of regenerative medicine, cellular engineering, tissue engineering, systems biology, and synthetic biology to apply earnestly. However, the second phase of the Artificial Kidneyprize consists of 2 different paths or tracks.
The first one is “Accelerating the Prototype of a Bioartificial Kidney”. In this path, people will produce a plan for making a prototype bio-artificial kidney. They will also include a plan for its development and studies in humans.
The second path is “Components and Tools that Enable the Development of an Artificial Kidney”. This path or track is for people from the fields of medicine, biology, or engineering. In this track, people need to find a solution to a problem that hinders the development of an artificial kidney. Artificial kidneys can also have wearable or implantable options as well.
The submission period for both tracks or paths opens today. It closes on October 28, 2022, for path 1. It closes on January 28, 2023, for path 2. The funding will also be divided among 9 winners, 3 from path 1 and 6 from path 2. Path 1 winner will receive $1.5 million each. Path 2 winners will receive $1 million each.
The development of a fully functioning artificial kidney is a difficult process. However, the kidney should perform all the life-saving functions needed for the human body.
HHS said that there are 850 million people worldwide who live with kidney diseases, including 37 million Americans. They also mentioned that inn in the US alone; treatment costs more than $100 billion annually.
Each day, 13 people die waiting for a kidney transplant. Those on dialysis face a 50 percent mortality rate during the first five years of treatment. They explicitly mentioned that comm cities of color are disproportionately affected with increased incidence, fewer organs available for transplant, and poorer outcomes overall.